Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1.

作者: Michel Accad , Steven J. Smith , Dale L. Newland , David A. Sanan , Lloyd E. King

DOI: 10.1172/JCI9021

关键词:

摘要: Inhibitors of acyl CoA:cholesterol acyltransferase (ACAT) have attracted considerable interest as a potential treatment for atherosclerosis. Currently available inhibitors probably act nonselectively against the two known ACATs. One these enzymes, ACAT1, is highly expressed in macrophages atherosclerotic lesions, where it contributes to foam-cell formation. In this study, we examined effects selective ACAT1 deficiency mouse models setting severe hypercholesterolemia caused by apoE or LDL receptor (LDLR), total led marked alterations cholesterol homeostasis and extensive deposition unesterified skin brain. Bone marrow transplantation experiments demonstrated that was sufficient cause dermal xanthomas hyperlipidemic LDLR-deficient mice. did not prevent development lesions either apoE-deficient mice, despite causing relatively lower serum levels. However, ACAT1-deficient mice were atypical composition, with reduced amounts neutral lipids paucity advanced lesions. Although latter findings may be associated increased lesion stability, indicate selectively inhibiting hyperlipidemia detrimental consequences.

参考文章(36)
Ira Tabas, Free Cholesterol-Induced Cytotoxicity Trends in Cardiovascular Medicine. ,vol. 7, pp. 256- 263 ,(1997) , 10.1016/S1050-1738(97)00086-8
C.C. Chang, H.Y. Huh, K.M. Cadigan, T.Y. Chang, Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. Journal of Biological Chemistry. ,vol. 268, pp. 20747- 20755 ,(1993) , 10.1016/S0021-9258(19)36846-2
K E Suckling, E F Stange, Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism. Journal of Lipid Research. ,vol. 26, pp. 647- 671 ,(1985) , 10.1016/S0022-2275(20)34322-4
V Meiner, C Tam, M D Gunn, L M Dong, K H Weisgraber, S Novak, H M Myers, S K Erickson, R V Farese, Tissue expression studies on the mouse acyl-CoA: cholesterol acyltransferase gene (Acact): findings supporting the existence of multiple cholesterol esterification enzymes in mice. Journal of Lipid Research. ,vol. 38, pp. 1928- 1933 ,(1997) , 10.1016/S0022-2275(20)37168-6
Aykut Bilge, Concepcion V. Warner, Oliver W. Press, Translocation of ricin A-chain into proteoliposomes reconstituted from Golgi and endoplasmic reticulum. Journal of Biological Chemistry. ,vol. 270, pp. 23720- 23725 ,(1995) , 10.1074/JBC.270.40.23720
Richard A. Anderson, Charles Joyce, Matthew Davis, Jerry W. Reagan, Michelle Clark, Gregory S. Shelness, Lawrence L. Rudel, Identification of a Form of Acyl-CoA:Cholesterol Acyltransferase Specific to Liver and Intestine in Nonhuman Primates * Journal of Biological Chemistry. ,vol. 273, pp. 26747- 26754 ,(1998) , 10.1074/JBC.273.41.26747
Peter Hasselbacher, Jeanie L. Hahn, Activation of the alternative pathway of complement by microcrystalline cholesterol Atherosclerosis. ,vol. 37, pp. 239- 245 ,(1980) , 10.1016/0021-9150(80)90009-X
Yumiko Asami, Izumi Yamagishi, Shigeru Murakami, Hiroaki Araki, Katsuharu Tsuchida, Shohei Higuchi, HL-004, the ACAT inhibitor, prevents the progression of atherosclerosis in cholesterol-fed rabbits. Life Sciences. ,vol. 62, pp. 1055- 1063 ,(1998) , 10.1016/S0024-3205(98)00028-9
Gerhard R. Lindeskog, Serum Lipoprotein Deficiency in Diffuse "Normolipemic" Plane Xanthoma Archives of Dermatology. ,vol. 106, pp. 529- 532 ,(1972) , 10.1001/ARCHDERM.1972.01620130057012
Brian R Krause, Drago R Sliskovic, Thomas Ma Bocan, Section Review—Cardiovascular & Renal: Emerging Therapies in Atherosclerosis Expert Opinion on Investigational Drugs. ,vol. 4, pp. 353- 387 ,(1995) , 10.1517/13543784.4.5.353